Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$31.57 - $37.73 $34,727 - $41,503
-1,100 Reduced 15.75%
5,882 $219,000
Q1 2023

Apr 28, 2023

BUY
$29.72 - $41.45 $207,505 - $289,403
6,982 New
6,982 $223,000
Q1 2022

Apr 27, 2022

SELL
$34.38 - $65.77 $294,636 - $563,648
-8,570 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$63.78 - $97.86 $269,470 - $413,458
4,225 Added 97.24%
8,570 $605,000
Q3 2021

Oct 21, 2021

SELL
$45.58 - $88.24 $232,594 - $450,288
-5,103 Reduced 54.01%
4,345 $692,000
Q2 2021

Jul 29, 2021

BUY
$34.4 - $48.34 $325,011 - $456,716
9,448 New
9,448 $892,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.